about
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOXCelecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 TrialThe iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancersInterplay between PFBC-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis
P50
description
researcher
@en
wetenschapper
@nl
name
Sandrine Tury
@en
Sandrine Tury
@nl
type
label
Sandrine Tury
@en
Sandrine Tury
@nl
prefLabel
Sandrine Tury
@en
Sandrine Tury
@nl
P31
P496
0000-0001-9291-734X